Biotechnology News

April 23, 2012

TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Biovest and the US Army are collaborating to establish hollow fiber bioreactors as an ideal manufacturing platform for the rapid, robust and cost-effective production of anti-viral vaccines and...

April 23, 2012

BEIJING--(BUSINESS WIRE)--Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”) , a technology-focused supplier of hybrid and genetically modified crop seeds in China, today announced its operating company, Beijing Origin Seed...

April 23, 2012

WASHINGTON--(BUSINESS WIRE)--Association of Clinical Research Organizations (ACRO) Testifies to FDA on Clinical Trial Modernization and Need for Chief Innovation Officer

April 23, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles today announced the appointment of Tom Pike as chief executive officer. Dennis Gillings, CBE, who founded the company, continues as executive chairman of its Board of Directors.

April 23, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--NextBio Clinical extends the NextBio research platform from the bench to translational medicine and biomarker discovery, correlating patient clinical and genomic data to experimental ‘-Omics’.

April 23, 2012

SAVANNAH, Ga.--(BUSINESS WIRE)--Retinalyze, LLC Begins Enrolling Ophthalmology Practices

April 23, 2012

PINE BROOK, N.J. & HIROSAKI, Japan--(BUSINESS WIRE)--Ezose Sciences will use its proprietary glycan-analysis technology in research to identify cancer biomarkers.

April 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the election of Dennis A. Ausiello, M.D. to its Board of Directors and Scientific Advisory Board. Dr. Ausiello...

April 23, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (ISCO.OB), www.internationalstemcell.com, today announced that several of its senior...

April 23, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB: ISCO) (www.internationalstemcell.com) today announced it has appointed MZ...

April 23, 2012

KIRKLAND, Wash.--(BUSINESS WIRE)--ProteoTech's CSO to Present New Data at the XIIIth International Symposium on Amyloidosis in Netherlands, May 6-10, 2012

April 23, 2012

CHICAGO--(BUSINESS WIRE)--ClearTrial to present at Bio-IT World Conference & Expo on how life sciences companies are leveraging cloud-based systems to integrate and connect siloed functions to increase operational efficiency.

April 23, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--W. R. Grace & Co. (NYSE: GRA) and Formac Pharmaceuticals announce successful clinical trial demonstrating the novel use of silica for drug delivery.

April 23, 2012

PLEASANTON, Calif.--(BUSINESS WIRE)--IntegenX Inc. today announced that it has acquired an IP portfolio of DNA consumables from GE Healthcare Bio-Sciences for its rapid human identification system.

April 23, 2012

NEW HAVEN, Conn.--(BUSINESS WIRE)--Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced the appointment of Gerald McMahon, Ph.D., as President and Chief Executive Officer. Dr. McMahon, who also has been nominated...

April 23, 2012

NEW YORK--(BUSINESS WIRE)--OrbiMed, a leading global investment management firm focused on the healthcare sector, is pleased to announce the closing of its first investment fund dedicated to life sciences venture capital opportunities based in...

April 23, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Meritas Health Corporation has chosen eClinicalWorks as its electronic medical records system. Meritas Health Corporation is a multi-specialty group in Kansas City, Mo., with 72 employed physicians.

April 23, 2012

MALVERN, Pa.--(BUSINESS WIRE)--John M. Gill, TetraLogic Pharmaceuticals’ President and Chief Executive Officer, received the prestigious annual Semper Fidelis Award which is presented each year to an outstanding American who has maintained...

April 23, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natus Medical Incorporated (NASDAQ:BABY) today announced that Natus management will host an investment-community conference call this morning, Monday, April 23, 2012 beginning at 9:00 a.m. Eastern Time (6:00 a...

April 23, 2012

NEW YORK--(BUSINESS WIRE)--One in seven US couples infertile, but cannot afford $15,000 for IVF – new technology cleared by FDA provides similar pregnancy rate for $795

April 23, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx announced the release today of its investor relations app for iPhone.

April 23, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen announced that the Company will host a conference call at 10:00 AM EST on Tuesday, May 1, 2012 to review first quarter 2012 results.

April 23, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Embarked on a Long-term Manufacturing Plan to Expand Capacity and Build ‘Ready-to-Ship’ Inventory Reserves.

April 23, 2012

MALVERN, Pa.--(BUSINESS WIRE)--Ariosa Diagnostics has chosen to use DSG's eCaseLink EDC (electronic data capture) system for the NEXT (Non-Invasive Chromosomal Examination of Trisomy) study.

April 23, 2012

DUBAI--(BUSINESS WIRE)--World Heart Federation, World Congress of Cardiology Scientific Sessions 2012 - April 23, 2012 Seventy patient and professional organisations from 39 countries united in Dubai this week at the World Heart Federation’s...

April 23, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer today announced that it has entered into an agreement to divest its Nutrition business to Nestlé for $11.85 billion in cash. Pfizer’s Nutrition business recorded revenues of approximately $2.1 billion in 2011, an...

April 22, 2012

TOKYO & NEW YORK--(BUSINESS WIRE)--Asahi Kasei Corporation (TSE1: 3407, hereinafter: Asahi Kasei), Japan’s leading diversified chemical manufacturer with businesses in the health care, chemicals & fibers, homes & construction...

April 21, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Presidio Pharmaceuticals, Inc. announced today that PPI-383, a novel non-nucleoside polymerase inhibitor to treat hepatitis C virus (HCV), has been nominated for clinical development and will be profiled by Richard...

April 20, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) will highlight its commitment to using novel science to address unmet medical needs in neurology at the upcoming 64th American Academy of Neurology (AAN) Annual Meeting. The meeting, held...

April 20, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that it will sponsor a conference call to discuss its financial results for the quarter ended March 31, 2012. These results are expected to be disclosed...

April 20, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is thrilled to welcome Andrew Pitsicalis as International Brand and...

April 20, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization announces that Governor Jon Huntsman, former U.S. Ambassador to China and Governor of Utah, will provide a keynote address at the BIO Convention in China.

April 20, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Medical science liaisons’ role in building key opinion leader relationships and managing scientific information continues to change and grow substantially.

April 20, 2012

WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH) announced today that following its request for re-examination, the European Medicines Agency’s Committee For Medicinal Products for Human Use (CHMP) confirmed its...

April 20, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the approval of...

April 20, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today a European Union (EU) regulatory milestone from Novartis. The milestone includes a $40 million payment earned based on the recommendation by the Committee for...

April 20, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it will release its first quarter 2012 financial results on Wednesday, May 9, 2012. Teva will host a conference call and live webcast on the same...

April 20, 2012

BOSTON--(BUSINESS WIRE)--HighRes Biosolutions brings robotics expertise to the world of exotic aquariums on a new episode of Animal Planet’s hit reality television series Tanked, featuring a one-of-a-kind robotic aquarium.

April 20, 2012

ALAMEDA, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex:BTX) and its wholly owned subsidiary LifeMap Sciences today announced that they have signed a definitive agreement to acquire XenneX, Inc. through a merger of...

April 20, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today the dosing of the third patient in its Phase I/II trial for dry age-related macular...

April 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today positive results from its Phase I clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the...

April 20, 2012

ROCKLAND, Mass.--(BUSINESS WIRE)--EMD Serono, Inc. announced that new data from the company’s multiple sclerosis portfolio will be presented at the American Academy of Neurology’s 64th Annual Meeting.

April 20, 2012

DUBAI, United Arab Emirates--(BUSINESS WIRE)--Boehringer Ingelheim announced today the launch of the GLORIATM-AF Registry Program, which is set to become the largest worldwide registry with the aim of understanding the long-term use of oral...

April 20, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: At Vitrolife’s Annual General Meeting yesterday, April 19, the following, amongst other things, was decided: · The Board’s proposed dividend of SEK 0.60 per share for the financial year 2011 was...

April 20, 2012

SADDLE BROOK, N.J. & AACHEN, Germany--(BUSINESS WIRE)--CircuLite today announced updated clinical data related to the Synergy miniature ventricular support system, as well as the successful implantation of Synergy in its 51st patient.

April 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme announced today that 12 data presentations from the company’s MS clinical trial programs for alemtuzumab and teriflunomide will be featured at the AAN annual meeting.

April 19, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--The OPUS Health division of Cegedim Relationship Management today announced the expansion of its patient acquisition and retention portfolio. OPUS Health’s newest solution allows pharmaceutical manufacturers to...

April 19, 2012

SALT LAKE CITY--(BUSINESS WIRE)--The U.S. healthcare system suffers from a glaring, persistent need to protect patients from unsafe IV infusions. Contaminated IV lines result in unnecessary patient injuries and death, and cost hospitals billions...

April 19, 2012

SEOUL, Korea, & FAIR LAWN, N.J.--(BUSINESS WIRE)--Designation as an Orphan Drug has been granted by the US FDA to carisbamate, from SK Biopharmaceuticals, for the management of patients with infantile spasms, an Orphan Disease.